Neocis Inc., a Propel(x) alumni company, is transforming dental implant surgery with robotics. The company developed Yomi®, the first and only FDA-cleared robotic system for dental implant surgery.
Yomi integrates digital treatment planning with real-time haptic guidance. As a result, clinicians can place implants with greater accuracy, efficiency, and consistency. This approach sets a new standard for precision in dental care.
Recent Milestones at Neocis
Over the past year, Neocis has reached several important milestones:
- Raised $20 million in growth funding, led by Mirae Asset Global Investments and NVIDIA’s NVentures, to accelerate commercialization and product innovation
- Published independent clinical studies confirming that Yomi-assisted implant placement delivers higher accuracy than conventional techniques
- Reported a 137% year-on-year increase in implant volume among practices using Yomi, demonstrating strong clinical and commercial impact
- Named one of Dentistry Today’s Top 25 Most Innovative Implant Products for 2025
- Expanded adoption across the U.S. and international markets, with growing use among leading dental clinics
Why This Matters
Robotics and digital technologies are reshaping healthcare delivery. Neocis robotic dental implant surgery improves patient outcomes, increases clinical efficiency, and strengthens the economics of dental practices.
At Propel(x), we’re proud to support Neocis as it brings precision robotics into everyday dental care.
Register on Propel(x) to explore and invest in the future of innovation:
https://www.propelx.com/
